StockData

VitaSpring Biomedical Co. Ltd. (VSBC) stock

VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.58MP/E –Yield –

VitaSpring Biomedical enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

VitaSpring Biomedical's enterprise value was $6.57M on Oct 19, 2026, against $207.03M a year earlier. Over the last 5 years it ranged from $2.28M to $4.03B, with a median of $2.97B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$6.57M-96.8%
2025Dec 31, 2025$207.03M-93.7%
2024Dec 31, 2024$3.31B+0.1%
2023Dec 29, 2023$3.31B+11.3%
2022Dec 30, 2022$2.97B-26.1%
2021Dec 31, 2021$4.03B+9391005.1%
2020Dec 31, 2020$42.88K-99.1%
2019Dec 31, 2019$4.58M–

More VitaSpring Biomedical figures

See a number that looks wrong?